Quantum-Si (NASDAQ:QSI) CEO Sells $30,344.96 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 23,707 shares of the company’s stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $30,344.96. Following the completion of the transaction, the chief executive officer owned 2,578,018 shares of the company’s stock, valued at $3,299,863.04. The trade was a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Quantum-Si Stock Performance

QSI remained flat at $1.27 during midday trading on Monday. The company’s stock had a trading volume of 5,071,186 shares, compared to its average volume of 3,958,795. Quantum-Si Incorporated has a 52 week low of $0.95 and a 52 week high of $5.77. The firm has a 50-day simple moving average of $1.66 and a 200-day simple moving average of $1.58. The firm has a market capitalization of $273.67 million, a price-to-earnings ratio of -1.90 and a beta of 2.97.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share for the quarter, hitting the consensus estimate of ($0.17). Quantum-Si had a negative net margin of 3,677.97% and a negative return on equity of 47.90%. The business had revenue of $0.55 million for the quarter, compared to analyst estimates of $0.60 million. On average, sell-side analysts forecast that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Canaccord Genuity Group decreased their price target on Quantum-Si from $2.00 to $1.50 and set a “hold” rating for the company in a report on Monday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Quantum-Si in a research note on Monday, December 8th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $3.60.

Hedge Funds Weigh In On Quantum-Si

Hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd acquired a new position in shares of Quantum-Si during the third quarter valued at approximately $84,000. Shay Capital LLC raised its holdings in shares of Quantum-Si by 19.2% during the third quarter. Shay Capital LLC now owns 154,572 shares of the company’s stock valued at $218,000 after acquiring an additional 24,941 shares during the period. Bridgeway Capital Management LLC boosted its position in shares of Quantum-Si by 33.1% in the third quarter. Bridgeway Capital Management LLC now owns 261,100 shares of the company’s stock worth $368,000 after buying an additional 65,000 shares during the period. Squarepoint Ops LLC acquired a new stake in shares of Quantum-Si during the 3rd quarter valued at $865,000. Finally, BNP Paribas Financial Markets increased its holdings in Quantum-Si by 101.3% in the third quarter. BNP Paribas Financial Markets now owns 30,464 shares of the company’s stock worth $43,000 after buying an additional 15,331 shares during the last quarter. 39.90% of the stock is currently owned by institutional investors and hedge funds.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.